The PKvitality team is proud to announce the start of the first clinical trials for K’Watch Glucose, the first smartwatch that measures glucose level continuously, effortlessly, and painlessly. This is a major milestone for our company that will confirm the accuracy and the patient-friendly experience of our product.

The Series A fundraising tour remains open to Business Angels until end of December 2021, funds that will allow us to optimize these trials.

More information in the full press release below

PKvitality is accelerated by 3DEXPERIENCE Lab ​​​​​​​